Immunisation with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters (Q40828965)

24 September 2017

title

Immunisation with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters (English)

1 reference

24 September 2017

1 reference

Fragaki K

1

1 reference

24 September 2017

Suffia I

2

1 reference

24 September 2017

Ferrua B

3

1 reference

24 September 2017

Rousseau D

4

1 reference

24 September 2017

Le Fichoux Y

5

1 reference

24 September 2017

Kubar J

6

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

24 September 2017

1 reference

24 September 2017

volume

19

1 reference

24 September 2017

issue

13-14

1 reference

24 September 2017

page(s)

1701-1709

1 reference

Global control and Leishmania HIV co-infection

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Clinical spectrum of Leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

New perspectives on a subclinical form of visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Transmission of L. infantum by blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Recent strategies for the chemotherapy of visceral leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Lack of a nitric-oxide response during the course of Leishmania infantum infection in the golden hamster (Mesocricetus auratus), with or without treatment with liposomal amphotericin B

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Reinfection in American cutaneous leishmaniasis: evaluation of clinical outcomes in the hamster model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L. major plus BCG

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

ISCOMs vaccine against experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Vaccination against Leishmania major in a CBA mouse model of infection: role of adjuvants and mechanism of protection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

BCG Expressing LCR1 of Leishmania chagasi Induces Protective Immunity in Susceptible Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of Leishmania donovani.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Long-term protection of mice against Leishmania major with a synthetic peptide vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

A novel Leishmania infantum recombinant antigen which elicits interleukin 10 production by peripheral blood mononuclear cells of patients with visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

DNA vaccination strategies against infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

DNA vaccines: technology and application as anti-parasite and anti-microbial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Resistance to Leishmania major induced by tolerance to a single antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

The scanning model for translation: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Th1-biased immune responses induced by DNA-based immunizations are mediated via action on professional antigen-presenting cells to up-regulate IL-12 production.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Short report: occurrence of Leishmania donovani DNA in donated blood from seroreactive Brazilian blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

Visceral leishmaniosis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900398-4

7 January 2021

10.1016/S0264-410X(00)00398-4

Identifiers

DOI

1 reference

24 September 2017

1 reference